Miquel Serra‐Burriel - Publications, H-index & Citations

Miquel Serra‐Burriel

university of zurich

31H指数

135论文数

4.3K被引数

收录论文 53

发表时间

Quantification of Age and Sex Ratio Differences between Trial and Target Population for New Drugs 新药临床试验与目标人群中年龄和性别比例差异的量化

CLINICAL PHARMACOLOGY & THERAPEUTICS

IF5.5

2026-02-01

OAAI

Miquel Serra-Burriel; Paul Schlossmacher; Kerstin Noelle Vokinger

ESMO-MCBS v2.0: Advances, challenges, and perspectives in the assessment of clinical benefit in oncology ESMO-MCBS v2.0：肿瘤学中临床获益评估的进展、挑战与展望

JHEP Reports

IF7.5

2025-09-24

OAAI

Ezequiel Mauro; Miquel Serra-Burriel

Colonoscopy versus faecal immunochemical testing in COLONPREV – Authors' reply 结肠镜检查与粪便免疫化学检测在COLONPREV研究中的比较——作者回复

lancet

IF0

2025-09-18

PREAI

Antoni Castells; Enrique Quintero; Miquel Serra-Burriel

Liver Health: An Emerging Concept 肝脏健康：一个新兴概念

Gastroenterology

IF25.1

2025-02-03

OAAI

Pere Ginès; Indra Neil Guha; Núria Fabrellas; Alina M. Allen; Paolo Angeli; Miquel Serra-Burriel

Why effect sizes are systematically larger for progression-free survival than overall survival in cancer drug trials: Prognostic scores as a way forward

EUROPEAN JOURNAL OF CANCER

IF7.1

2024-12-01

OAAI

Locher, Luca; Serra-Burriel, Miquel; Trapani, Dario; Nussli, Emanuel; Vokinger, Kerstin N.

Launch and Postlaunch Price Developments of New Drugs in the US, Germany, and Switzerland

JAMA HEALTH FORUM

IF11.3

2024-11-27

OAAI

Laube, Yannic; Serra-Burriel, Miquel; Glaus, Camille C. E. G.; Vokinger, Kerstin N.

Time From Approval to Reimbursement of New Drugs: A Comparative Analysis Between the United States, England, Germany, France, and Switzerland (2011-2022)

ANNALS OF INTERNAL MEDICINE

IF15.2

2024-10-01

PREAI

Glaus, Camille E. G.; Serra-Burriel, Miquel; Dusetzina, Stacie B.; Vokinger, Kerstin N.

Time from approval to reimbursement of new cancer and non-cancer drugs: A comparative analysis between the US, England, Germany, and Switzerland (2011-2022)从批准到报销的时间：新癌症药物和非癌症药物的对比分析（美国、英格兰、德国和瑞士，2011-2022年）

ANNALS OF ONCOLOGY

IF65.4

2024-09-01

PREAI

Glaus, C.; Serra-Burriel, M.; Dusetzina, S.; Vokinger, K. N.

Analysis of concordance between trial and target populations for cancer drugs in the US, EU, and Switzerland (2014-2023)2014-2023年美国、欧盟和瑞士癌症药物试验人群与目标人群之间的符合性分析

ANNALS OF ONCOLOGY

IF65.4

2024-09-01

PREAI

Vokinger, K. N.; Glaus, C.; Serra-Burriel, M.; Kesselheim, A.

Glucagon-Like Peptide-1 Receptor Agonists for Treatment of Steatotic Liver Disease in Patients With Type 2 Diabetes Mellitus: Growing Evidence But Not Yet There 胰高血糖素样肽-1受体激动剂治疗2型糖尿病患者的脂肪性肝病: 越来越多的证据，但还没有

GASTROENTEROLOGY

IF25.1

2024-09-01

OAAI

Gines, Pere; Serra-burriel, Miquel

Drug Prices After Patent Expirations in High-Income Countries and Implications for Cost-Effectiveness Analyses

JAMA HEALTH FORUM

IF11.3

2024-08-16

OAAI

Serra-Burriel, Miquel; Martin-Bassols, Nicolau; Perenyi, Gellert; Vokinger, Kerstin N.

Real-World Cost-Effectiveness of Pulmonary Vein Isolation for Atrial Fibrillation: A Target Trial Approach 肺静脉隔离治疗房颤的真实成本效益: 目标试验方法

VALUE IN HEALTH

IF6

2023-12-01

OAAI

Serra-Burriel, Miquel; Aebersold, Helena; Foster-Witassek, Fabienne; Coslovsky, Michael; Rodondi, Nicolas; Blum, Manuel R.; Sticherling, Christian; Moschovitis, Giorgio; Beer, Juerg H.; Reichlin, Tobias; Krisai, Philipp; Aeschbacher, Stefanie; Paladini, Rebecca E.; Kuehne, Michael; Osswald, Stefan; Conen, David; Felder, Stefan; Schwenkglenks, Matthias

Longitudinal Changes in Health-Related Quality of Life in Patients With Atrial Fibrillation 心房颤动患者健康相关生活质量的纵向变化

JOURNAL OF THE AMERICAN HEART ASSOCIATION

IF5.3

2023-11-07

OAAI

Foster-Witassek, Fabienne; Aebersold, Helena; Aeschbacher, Stefanie; Ammann, Peter; Beer, Juerg H.; Blozik, Eva; Bonati, Leo H.; Cattaneo, Mattia; Coslovsky, Michael; Felder, Stefan; Moschovitis, Giorgio; Mueller, Andreas; Netzer, Seraina; Paladini, Rebecca E.; Reichlin, Tobias; Rodondi, Nicolas; Stauber, Annina; Sticherling, Christian; Szucs, Thomas; Conen, David; Kuehne, Michael; Osswald, Stefan; Serra-Burriel, Miquel; Schwenkglenks, Matthias

Regulatory Review Duration and Differences in Submission Times of Drugs in the United States and Europe, 2011 to 2020

ANNALS OF INTERNAL MEDICINE

IF15.2

2023-10-01

PREAI

Vokinger, Kerstin N.; Serra-Burriel, Miquel; Glaus, Camille E. G.; Rohr, Ulrich-Peter; Hwang, Thomas J.; di Sanguinetto, Simon Dalla Torre; Kesselheim, Aaron S.

Therapeutic value of first vs supplemental indications of drugs in the US and Europe (2011-2020): Retrospective cohort study

ANNALS OF ONCOLOGY

IF65.4

2023-10-01

OAAI

Vokinger, K. N.; Glaus, C.; Kesselheim, A.; Serra-Burriel, M.; Ross, J.; Hwang, T.

Cancer premium: Explaining differences in prices for cancer vs non-cancer drugs with efficacy and epidemiological endpoints in the US, Germany, and Switzerland

ANNALS OF ONCOLOGY

IF65.4

2023-10-01

OAAI

Serra-Burriel, M.; Perenyi, G.; Laube, Y.; Mitchell, A.; Vokinger, K. N.

Development, validation, and prognostic evaluation of a risk score for long-term liver-related outcomes in the general population: a multicohort study 普通人群长期肝脏相关结局风险评分的制定、验证和预后评估: 一项多职业研究

LANCET

IF88.5

2023-09-01

OAAI

Serra-Burriel, Miquel; Juanola, Adria; Serra-Burriel, Feliu; Thiele, Maja; Graupera, Isabel; Pose, Elisa; Pera, Guillem; Grgurevic, Ivica; Caballeria, Llorenc; Piano, Salvatore; van Kleef, Laurens; Reichert, Mathias; Roulot, Dominique; Pericas, Juan M.; Schattenberg, Joern M.; Tsochatztis, Emmanuel A.; Guha, Indra Neil; Garcia-Retortillo, Montserrat; Hernandez, Rosario; Hoyo, Jordi; Fuentes, Matilde; Exposito, Carmen; Martinez, Alba; Such, Patricia; Madir, Anita; Detlefsen, Sonke; Tonon, Marta; Martini, Andrea; Ma, Ann T.; Pich, Judith; Bonfill, Eva; Juan, Marta; Soria, Anna; Carol, Marta; Gratacos-Gines, Jordi; Morillas, Rosa M.; Toran, Pere; Navarrete, J. M.; Torrejon, Antoni; Fournier, Celine; Llorca, Anne; Arslanow, Anita; de Koning, Harry J.; Cucchietti, Fernando; Manns, Michael; Newsome, Phillip N.; Hernaez, Ruben; Allen, Alina; Angeli, Paolo; de Knegt, Robert J.; Karlsen, Tom H.; Galle, Peter; Wong, Vincent Wai-Sun; Fabrellas, Nuria; Castera, Laurent; Krag, Aleksander; Lammert, Frank; Kamath, Patrick S.; Gines, Pere

Therapeutic value of first versus supplemental indications of drugs in US and Europe (2011-20): retrospective cohort study

BMJ-BRITISH MEDICAL JOURNAL

IF42.7

2023-07-05

OAAI

Vokinger, Kerstin N.; Glaus, Camille E. G.; Kesselheim, Aaron S.; Serra-Burriel, Miguel; Ross, Joseph S.; Hwang, Thomas J.

The cancer premium-explaining differences in prices for cancer vs non-cancer drugs with efficacy and epidemiological endpoints in the US, Germany, and Switzerland: a cross sectional

ECLINICALMEDICINE

IF10

2023-07-01

OAAI

Serra-Burriel, Miquel; Perenyi, Gellert; Laube, Yannic; Mitchell, Aaron P.; Vokinger, Kerstin N.

LiverScreen project: study protocol for screening for liver fibrosis in the general population in European countries (vol 22, 1385, 2022)LiverScreen项目: 欧洲国家普通人群中肝纤维化筛查的研究方案 (第22卷，1385，2022)

BMC PUBLIC HEALTH

IF3.6

2023-05-22

OAAI

Graupera, Isabel; Thiele, Maja; Ma, Ann T.; Serra-Burriel, Miquel; Pich, Judit; Fabrellas, Nuria; Caballeria, Llorenc; de Knegt, Robert J.; Grgurevic, Ivica; Reichert, Mathias; Roulot, Dominique; Schattenberg, Joern M.; Pericas, Juan M.; Angeli, Paolo; Tsochatzis, Emmanuel A.; Guha, Indra Neil; Garcia-Retortillo, Montserrat; Morillas, Rosa M.; Hernandez, Rosario; Hoyo, Jordi; Fuentes, Matilde; Madir, Anita; Juanola, Adria; Soria, Anna; Juan, Marta; Carol, Marta; Diaz, Alba; Detlefsen, Soenke; Toran, Pere; Pera, Guillem; Fournier, Celine; Llorca, Anne; Newsome, Phillip N.; Manns, Michael; de Koning, Harry J.; Serra-Burriel, Feliu; Cucchietti, Fernando; Arslanow, Anita; Korenjak, Marko; van Kleef, Laurens; Falco, Josep Lluis; Kamath, Patrick S.; Karlsen, Tom H.; Castera, Laurent; Lammert, Frank; Krag, Aleksander; Gines, Pere

研究方向